Current status for the treatment of extranodal nasal type NK/T cell lymphoma
10.3760/cma.j.issn.1673-422X.2015.07.022
- VernacularTitle:结外鼻型NK/T细胞淋巴瘤治疗现状
- Author:
Hengmin TAO
;
Baosheng LI
- Publication Type:Journal Article
- Keywords:
Lymphoma,extranodal NK-T-cell;
Radiotherapy;
Drug therapy;
Hematopoietic stem cell transplantation
- From:
Journal of International Oncology
2015;(7):554-556
- CountryChina
- Language:Chinese
-
Abstract:
The most of extranodal nasal type NK/ T-cell lymphoma(ENKTL)are in the Ⅰ/ Ⅱ stage. Radiotherapy alone is insufficient to achieve a high cure rate for the early stage patients with ENKTL due to fre-quent local and systemic relapse. Concomitant/ sequential chemotherapy and radiotherapy is the standard treat-ment for the early stage patients with ENKTL. For the patients with stage Ⅲ/ Ⅳ ENKTL,regimens containing L-asparaginase are most effective. For the patients with advanced stage ENKTL or refractory recurrent ENKTL, hematopoietic stem cell transplantation may be considered when the remission is achieved.
